Project Grant HT9425261E142
- Federal Grant Award Summary The University of Utah's Office of Sponsored Projects received a $1,395,804 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026, through June 30, 2029. This award supports research investigating exposure-induced lung injury and interventions to prevent early lung cancer progression. The research will be conducted at the University of Utah's Salt Lake City campus and is designed...
- Federal Project Grant Award Summary The University of Utah's Office of Sponsored Projects received a $559,972 project grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, through May 31, 2028. The award supports research investigating engineered macrophages as a therapeutic intervention to prevent melanoma metastatic spread. This two-year project aligns with the DHA's strategic focus on innovative...
- Federal Grant Award Summary The University of Utah's Office of Sponsored Projects received a $369,872 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on temporal coding of the human auditory nerve. The award was issued on September 1, 2025, with an ultimate completion date of August 31, 2027. This research initiative will be conducted at the University of Utah's primary location in Salt Lake City,...
- Federal Grant Award Summary Utah State University received a $1.62 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2026 through June 30, 2030. The award supports a randomized controlled trial evaluating an online self-guided Acceptance and Commitment Therapy (ACT) intervention designed for military caregivers. The project employs a mixed-methods evaluation approach to assess the intervention's...
- Federal Grant Award Summary The Defense Health Agency awarded the University of Utah a $1.56 million Project Grant under the Military Health Services Research (MHSR) Program (CFDA 12.007) for a two-year initiative titled "Using Telehealth to Improve Musculoskeletal Care Through Expanded Physical Therapy Access: The Tele-MC Trial," effective September 1, 2025 through August 31, 2027. This research project will evaluate telehealth implementation strategies to expand physical therapy...
- Federal Project Grant Award Summary The University of Miami's Office of Research Administration at the School of Medicine received a $1,092,670 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded June 15, 2026, with completion targeted for June 14, 2030. The award supports research titled "Bringing Alzheimer's Detection to the Front Lines: Evaluating Novel Cognitive and Plasma Biomarkers in Primary Care,"...
- This federal Project Grant award of $462,000.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, will support the University of Utah's research project titled "ADVANCING RISK PREDICTION AND PREVENTION TO MITIGATE THE BURDEN OF CARDIOVASCULAR DISEASE IN MEN WITH PROSTATE CANCER." The award, with a performance period from Sep 15, 2024 to Sep 14, 2026, will fund advanced biomedical research initiatives...
- Summary Columbia University's Health Sciences Division received a $301,632 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2026 through July 31, 2029. The award funds research titled "The Value of Hypertension Control to Prevent Dementia and Enhance Readiness: Generating Evidence from DoD-VHA Data, Patient Preferences and Health Economics." The research leverages integrated datasets from...
- This federal Project Grant award, totaling $3,602,532.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports the development of a sustained-release drug delivery device to manage biofilm implant-related infections in the spine and lateral femur. The primary awardee is the University of Utah, which has a strong track record of executing complex medical research projects for federal agencies. The...
- The University of Utah has been awarded a $824,512 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from June 1, 2024 to May 31, 2027, will fund research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." This project aims to leverage digital pathology techniques to improve the prediction of treatment outcomes for patients with hormone-sensitive...
The University of Utah received a $695,255 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) beginning August 1, 2026 and concluding July 31, 2029. The award supports research titled "The Value of Hypertension Control to Prevent Dementia and Enhance Readiness: Generating Evidence from DOD-VHA Data, Patient Preferences and Health Economics." This project will generate evidence-based research examining the relationship between hypertension management and dementia prevention by leveraging Department of Defense and Veterans Health Administration (VHA) data, incorporating patient preference assessments, and conducting health economic analyses. The research addresses military health priorities by investigating medical solutions relevant to Service Member readiness and broader public health objectives through hypothesis-driven investigation. Under this award, the University of Utah's Office of Sponsored Projects will deliver translational research services and biomarker/health outcomes analysis drawing from integrated DOD-VHA datasets. The project combines clinical evidence generation with health economics evaluation and patient preference research, aligning with the Military Medical Research and Development program's focus on transforming healthcare for Service Members and the American public through innovative, impactful research addressing critical neurological and cardiovascular health challenges. The three-year performance period reflects the program's standard award structure for applied biomedical research initiatives.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $695.3k | 5/1/26 |